- Home
- SMC vs SAGE Comparison
SMC vs SAGE Comparison
Compare SMC & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMC
- SAGE
- Stock Information
- Founded
- SMC 2009
- SAGE 2010
- Country
- SMC United States
- SAGE United States
- Employees
- SMC N/A
- SAGE N/A
- Industry
- SMC
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- SMC
- SAGE Health Care
- Exchange
- SMC NYSE
- SAGE Nasdaq
- Market Cap
- SMC 363.3M
- SAGE 415.0M
- IPO Year
- SMC 2012
- SAGE 2014
- Fundamental
- Price
- SMC $29.52
- SAGE $6.61
- Analyst Decision
- SMC
- SAGE Hold
- Analyst Count
- SMC 0
- SAGE 19
- Target Price
- SMC N/A
- SAGE $9.88
- AVG Volume (30 Days)
- SMC 63.6K
- SAGE 895.6K
- Earning Date
- SMC 05-07-2025
- SAGE 04-29-2025
- Dividend Yield
- SMC N/A
- SAGE N/A
- EPS Growth
- SMC N/A
- SAGE N/A
- EPS
- SMC N/A
- SAGE N/A
- Revenue
- SMC $444,383,000.00
- SAGE $47,404,000.00
- Revenue This Year
- SMC N/A
- SAGE $100.64
- Revenue Next Year
- SMC N/A
- SAGE $70.19
- P/E Ratio
- SMC N/A
- SAGE N/A
- Revenue Growth
- SMC N/A
- SAGE N/A
- 52 Week Low
- SMC $25.00
- SAGE $4.62
- 52 Week High
- SMC $45.89
- SAGE $14.56
- Technical
- Relative Strength Index (RSI)
- SMC 50.10
- SAGE 35.95
- Support Level
- SMC $25.00
- SAGE $6.50
- Resistance Level
- SMC $30.24
- SAGE $7.63
- Average True Range (ATR)
- SMC 1.55
- SAGE 0.28
- MACD
- SMC 0.45
- SAGE -0.09
- Stochastic Oscillator
- SMC 86.26
- SAGE 7.26
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.